Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Abbott Laboratories total current liabilities for 2024 were $14.157B, a 2.28% increase from 2023.
Abbott Laboratories total current liabilities for 2023 were $13.841B, a 10.64% decline from 2022.
Abbott Laboratories total current liabilities for 2022 were $15.489B, a 18.19% increase from 2021.

Abbott Laboratories Total Current Liabilities 2010-2025 | ABT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Abbott Laboratories total current liabilities for 2024 were $14.157B, a 2.28% increase from 2023.
Abbott Laboratories total current liabilities for 2023 were $13.841B, a 10.64% decline from 2022.
Abbott Laboratories total current liabilities for 2022 were $15.489B, a 18.19% increase from 2021.

Related Stocks
Company Name	Market Cap
Boston Scientific (BSX)	$140.7B
Stryker (SYK)	$132.3B
EssilorLuxottica (ESLOY)	$128.4B
Medtronic (MDT)	$105.9B
Lonza Group Ag (LZAGY)	$47.4B
Haleon (HLN)	$46.2B
ResMed (RMD)	$31.3B
Agilent Technologies (A)	$29.2B
GE HealthCare Technologies (GEHC)	$28.6B
Terumo (TRUMY)	$28.2B
Koninklijke Philips (PHG)	$22.2B
Zimmer Biomet Holdings (ZBH)	$19.4B
Insulet (PODD)	$17.3B
Baxter (BAX)	$14.8B
Smith & Nephew SNATS (SNN)	$11.4B
Sunny Optical Technology (SNPTF)	$7.6B
Lantheus Holdings (LNTH)	$6.9B
Bio-Rad Laboratories (BIO)	$6.7B
Demant (WILYY)	$6.6B
Prestige Consumer Healthcare (PBH)	$4B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Perrigo (PRGO)	$3.5B
ICU Medical (ICUI)	$3.4B
Haemonetics (HAE)	$2.9B
Envista Holdings (NVST)	$2.6B
GN Store Nord (GNNDY)	$2.2B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.7B
AtriCure (ATRC)	$1.6B
Kestra Medical Technologies (KMTS)	$1.2B